In the emerging evidence base on coronavirus disease 2019 and loss of smell, how many preprint papers are subsequently published?

Walsh, Maia E; Hopkins, Claire

Walsh, Maia E; Hopkins, Claire.

Walsh ME; Guy's Hospital, Guy's and St Thomas National Health Service (NHS) Foundation Trust, London, UK.
Hopkins C; Guy's Hospital, Guy's and St Thomas National Health Service (NHS) Foundation Trust, London, UK.

Int Forum Allergy Rhinol ; 11(7): 1128-1131, 2021 07.

Article in English | MEDLINE | ID: covidwho-1062096

Subject(s)

COVID-19; Olfaction Disorders; Peer Review, Research/methods; Publishing; COVID-19/complications; COVID-19/epidemiology; Humans; Information Dissemination/methods; Internationality; Olfaction Disorders/diagnosis; Olfaction Disorders/epidemiology; Olfaction Disorders/etiology; Publishing/organization & administration; Publishing/standards; Publishing/trends; SARS-CoV-2

Keywords

COVID-19; evidence-based medicine; olfaction; olfactory-based medicine; preprint

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Publishing / Peer Review, Research / COVID-19 / Olfaction Disorders Type of study: Diagnostic study / Observational study Topics: Long Covid Limits: Humans Language: English Journal: Int Forum Allergy Rhinol Year: 2021 Document Type: Article Affiliation country: Alr.22772

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google